Bank Of Montreal Cytokinetics Inc Transaction History
Bank Of Montreal
- $197 Billion
- Q2 2024
A detailed history of Bank Of Montreal transactions in Cytokinetics Inc stock. As of the latest transaction made, Bank Of Montreal holds 13,392 shares of CYTK stock, worth $743,256. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,392
Previous 11,665
14.8%
Holding current value
$743,256
Previous $817,000
11.26%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding CYTK
# of Institutions
404Shares Held
126MCall Options Held
3.29MPut Options Held
2.01M-
Black Rock Inc. New York, NY14.7MShares$814 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.4MShares$635 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD8.14MShares$452 Million0.28% of portfolio
-
Wellington Management Group LLP Boston, MA7.51MShares$417 Million0.07% of portfolio
-
State Street Corp Boston, MA6.55MShares$363 Million0.02% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $5.22B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...